Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Gilead-Sciences
Company Monitoring Page for Gilead-Sciences
latest headlines for company on cafepharma
8 key clinical trials to watch for the rest of 2021
BioPharma Dive
Mon, 06/21/21 - 11:11 am
Tags:
clinical trials
,
Merck
,
Ridgeback Biotherapeutics
,
COVID-19
,
Intellia Therapeutics
,
transthyretin amyloidosis
,
Arcus Biosciences
,
Gilead Sciences
,
lung cancer
,
Sanofi
,
GSK
,
vaccines
,
uniQure
,
Huntington's disease
,
Mirati Therapeutics
,
gene editing
,
Seres Therapeutics
,
ulcerative colitis
,
Sarepta Therapeutics
,
Duchenne Muscular Dystrophy
BMS will file for earlier-line use of Breyanzi in lymphoma after trial win
Pharmaforum
Fri, 06/11/21 - 10:49 am
Tags:
Bristol Myers Squibb
,
CAR-T
,
Breyanzi
,
large B-cell lymphoma
,
Novartis
,
Gilead Sciences
,
FDA
Arcus nears crunch time for Gilead opt-in
EP Vantage
Thu, 06/10/21 - 10:47 am
Tags:
Arcus Biosciences
,
anti-TIGIT
,
clinical trials
,
Gilead Sciences
,
monoclonal antibodies
ASCO21: Gilead sets up first FDA okay for adult ALL with Tecartus data
Pharmaforum
Mon, 06/7/21 - 11:07 am
Tags:
ASCO 2021
,
Gilead Sciences
,
Tecartus
,
ALL
#ASCO21: A week after nabbing priority review, Kite unveils the pivotal data it hopes will lead to a new CAR-T approval
Endpoints
Sat, 06/5/21 - 02:25 pm
Tags:
ASCO 2021
,
Kite Pharma
,
Gilead Sciences
,
CAR-T
,
Tecartus
#ASCO21: Gilead's Trodelvy reads out new subgroup data showing benefit in earlier-line TNBC patients
Endpoints
Fri, 06/4/21 - 11:00 am
Tags:
Gilead Sciences
,
Trodelvy
,
breast cancer
,
triple negative breast cancer
,
ASCO 2021
#ASCO21: Novartis gears up for CAR-T fight with Gilead in follicular lymphoma — and safety could define the battle
Endpoints
Thu, 06/3/21 - 10:51 am
Tags:
Novartis
,
ASCO 2021
,
CAR-T
,
Kymriah
,
follicular lymphoma
,
Gilead Sciences
,
Yescarta
Gilead's Q1 Results Show Just How Much the Biotech Is Relying on Its COVID Drug
Motley Fool
Fri, 04/30/21 - 10:34 am
Tags:
Gilead Sciences
,
earnings
Gilead, Merck step in to help India's drug manufacturers fight surging COVID-19 outbreak
Fierce Pharma
Tue, 04/27/21 - 11:26 pm
Tags:
Gilead Sciences
,
Merck
,
India
,
COVID-19
Quiet times return for biopharma takeouts
EP Vantage
Wed, 04/14/21 - 09:26 am
Tags:
M&A
,
Alexion
,
Amgen
,
AstraZeneca
,
Biogen
,
Five Prime Therapeutics
,
Gilead Sciences
,
GW Pharma
,
Horizon Therapeutics
,
Immunomedics
,
Jazz Pharmaceutical
,
Kymab
,
Merck
,
Pandion
,
Sanofi
,
Viela Bio
Gilead stops Veklury study, citing enrollment challenges, changing treatment
BioPharma Dive
Tue, 04/13/21 - 10:05 pm
Tags:
Gilead Sciences
,
COVID-19
,
remdesivir
,
Veklury
,
clinical trials
India axes exports of Gilead Sciences' remdesivir, plots boost to local production as COVID cases mount: reports
Fierce Pharma
Mon, 04/12/21 - 10:59 pm
Tags:
India
,
drug manufacturing
,
Gilead Sciences
,
remdesivir
,
COVID-19
Gilead scores US approval for breast cancer drug that wowed ESMO
Pharmaforum
Thu, 04/8/21 - 10:23 am
Tags:
Gilead Sciences
,
Trodelvy
,
FDA
,
ESMO
,
triple negative breast cancer
CEO Dan O'Day, tasked with boosting Gilead's oncology presence, scores $19M for a year focused on COVID
Fierce Pharma
Mon, 04/5/21 - 10:18 pm
Tags:
Gilead Sciences
,
Daniel O'Day
,
executive pay
,
Pharma CEOs
Pharma Gilead has sole rights to COVID-19 blockbuster Veklury, GAO concludes
Fierce Pharma
Thu, 04/1/21 - 11:42 pm
Tags:
Gilead Sciences
,
remdesivir
,
Veklury
,
GAO
,
COVID-19
Biotech pioneer and startup investor John Martin, who built Gilead into a powerhouse player, has died
Endpoints
Wed, 03/31/21 - 10:31 am
Tags:
Gilead Sciences
,
John Martin
,
Pharma CEOs
How Gilead's and Merck's Surprise Partnership Will Shake Up the HIV Market
Motley Fool
Thu, 03/25/21 - 11:46 am
Tags:
Gilead Sciences
,
Merck
,
HIV
,
drug development
Gilead, Novo Nordisk push NASH cocktail deeper into the clinic
Fierce Biotech
Thu, 03/18/21 - 10:54 am
Tags:
Gilead Sciences
,
Novo Nordisk
,
NASH
,
R&D
Gilead, Merck combine forces in HIV
BioPharma Dive
Mon, 03/15/21 - 11:51 pm
Tags:
Gilead Sciences
,
Merck
,
HIV
Aelix posts HIV vaccine data ahead of Gilead combo readout
Fierce Biotech
Thu, 03/11/21 - 10:37 am
Tags:
Aelix Therapeutics
,
HIV
,
vaccines
,
Gilead Sciences
Pages
« first
‹ previous
…
11
12
13
14
15
16
17
18
19
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
an umbrella protects you from: rain, sand, hunger
*
Fill in the blank.